Home NDC 75907-331 75907-331
Product NDC 75907-331
11-digit product format 759070331
Labeler code 75907
Product ID 75907-331_e23e9160-3a07-bdaf-a09e-283cc24f76c6
Type DRUG FOR FURTHER PROCESSING
Nonproprietary name Ibuprofen
Dosage form TABLET
Marketing category DRUG FOR FURTHER PROCESSING
Marketing start 2025-09-26
Substance IBUPROFEN
Active strength 400 mg/1
Listing certified through 2027-12-31
Current FDA listing Yes NDC auxiliary status# These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
Current NDC status page 1 of 1 · 2 matching rows.
Dataset, Scope, Product NDC table Dataset Scope Product NDC Package NDC Code Status Reporting period Source date unfinished product product 75907-331 UNFINISHED Active or certified unfinished drug listing 2026-10-12 unfinished package package 75907-331 75907-331-94 UNFINISHED Active or certified unfinished drug listing 2026-10-12
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 2 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-12-14 21:27 UTC · source 2025-12-05 unfinished product product 75907-331 UNFINISHED Active or certified unfinished drug listing unfinished / ndc_unfinished.zip a6255e0c9aa5…a0211a219f2e…2025-12-14 21:27 UTC · source 2025-12-05 unfinished package package 75907-331 75907-331-94 UNFINISHED Active or certified unfinished drug listing unfinished / ndc_unfinished.zip a6255e0c9aa5…a0211a219f2e…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product No
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength IBUPROFEN 400 mg/1
DailyMed Product Concepts# DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Status 75907-331-94 75907033194 4000 TABLET in 1 POUCH (75907-331-94) 4000 tablet 26-SEP-25 Current